Consolidative Radiotherapy to Residual Masses After Chemotherapy is Associated With Improved Outcome in Diffuse Large B-cell Lymphoma. a Retrospective, Population-Based Study

The role of radiotherapy (RT) in Diffuse Large B-cell lymphomas with advanced disease is unclear. In this retrospective study, two cooperating university hospitals in Western Norway had different practices in use of RT, but similar patient characteristics and chemotherapy. RT to a residual mass after chemotherapy, in low-intermediate risk groups with advanced disease, was associated with improved cancer-specific and overall survival.

Source: Clinical Lymphoma, Myeloma and Leukemia - December 22, 2017 Category: Hematology Authors: Øystein Fluge, Bård Mannsåker, Anders Torp, Ingvil Mjaaland, Lars Helgeland, Jan Klos, Olav Mella, Sigbjørn Berentsen, Peter Meyer Tags: Original Study Source Type: research